Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

168 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cystic Appearance on Imaging Methods (Bosniak III-IV) in Histologically Confirmed Papillary Renal Cell Carcinoma is Mainly Characteristic of Papillary Renal Cell Carcinoma Type 1 and Might Predict a Relatively Indolent Behavior of Papillary Renal Cell Carcinoma.
Procházková K, Mírka H, Trávníček I, Pitra T, Kolár J, Roušarová M, Hošek P, Bajcurová K, Ferda J, Staehler M, Brookman May SD, Hes O, Hora M. Procházková K, et al. Among authors: brookman may sd. Urol Int. 2018;101(4):409-416. doi: 10.1159/000492719. Epub 2018 Sep 10. Urol Int. 2018. PMID: 30199877
Impact of Peritoneal Interposition Flap on Patients Undergoing Robot-assisted Radical Prostatectomy and Pelvic Lymph Node Dissection: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
May M, Gilfrich C, Bründl J, Ubrig B, Wagner JR, Gloger S, Student V Jr, Merseburger AS, Thomas C, Brookman-May SD, Wolff I. May M, et al. Among authors: brookman may sd. Eur Urol Focus. 2024 Jan;10(1):80-89. doi: 10.1016/j.euf.2023.07.007. Epub 2023 Aug 3. Eur Urol Focus. 2024. PMID: 37541915
Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
Brookman-May S, May M, Shariat SF, Xylinas E, Stief C, Zigeuner R, Chromecki T, Burger M, Wieland WF, Cindolo L, Schips L, De Cobelli O, Rocco B, De Nunzio C, Feciche B, Truss M, Gilfrich C, Pahernik S, Hohenfellner M, Zastrow S, Wirth MP, Novara G, Carini M, Minervini A, Simeone C, Antonelli A, Mirone V, Longo N, Simonato A, Carmignani G, Ficarra V; Members of the CORONA project and the SATURN project. Brookman-May S, et al. Eur Urol. 2013 Sep;64(3):472-7. doi: 10.1016/j.eururo.2012.06.030. Epub 2012 Jun 22. Eur Urol. 2013. PMID: 22748912
Prognostic effect of sarcomatoid dedifferentiation in patients with surgically treated renal cell carcinoma: a matched-pair analysis.
Brookman-May S, May M, Shariat SF, Zigeuner R, Chromecki T, Cindolo L, Schips L, De Cobelli O, Rocco B, De Nunzio C, Tubaro A, Feciche B, Coman I, Truss M, Pahernik S, Wirth MP, Zastrow S, Dalpiaz O, Fenske F, Waidelich R, Stief C, Gunia S; Members of the CORONA Project. Brookman-May S, et al. Clin Genitourin Cancer. 2013 Dec;11(4):465-70. doi: 10.1016/j.clgc.2013.04.026. Epub 2013 Jun 29. Clin Genitourin Cancer. 2013. PMID: 23820063
Time to recurrence is a significant predictor of cancer-specific survival after recurrence in patients with recurrent renal cell carcinoma--results from a comprehensive multi-centre database (CORONA/SATURN-Project).
Brookman-May SD, May M, Shariat SF, Novara G, Zigeuner R, Cindolo L, De Cobelli O, De Nunzio C, Pahernik S, Wirth MP, Longo N, Simonato A, Serni S, Siracusano S, Volpe A, Morgia G, Bertini R, Dalpiaz O, Stief C, Ficarra V; Members of the CORONA-Project; Members of the SATURN-Project; Young Academic Urologists Renal Cancer Group. Brookman-May SD, et al. Among authors: may m. BJU Int. 2013 Nov;112(7):909-16. doi: 10.1111/bju.12246. Epub 2013 Jul 25. BJU Int. 2013. PMID: 23890378
Prediction of Locally Advanced Urothelial Carcinoma of the Bladder Using Clinical Parameters before Radical Cystectomy--A Prospective Multicenter Study.
Martini T, Aziz A, Roghmann F, Rink M, Chun FK, Fisch M, Trojan L, Hakenberg OW, Zastrow S, Wirth MP, Moersdorf J, Brookman-May S, Stief CG, Haferkamp A, Wagenlehner F, Hohenfellner M, Herrmann E, Lusuardi L, Grimm MO, Müller SC, Roigas J, Bastian PJ, Gierth M, Burger M, Pycha A, Seitz C, May M, Bolenz C. Martini T, et al. Urol Int. 2016;96(1):57-64. doi: 10.1159/000433606. Epub 2015 Jul 1. Urol Int. 2016. PMID: 26139354
Prognostic and discriminative power of the 7th TNM classification for patients with surgically treated papillary renal cell carcinoma: results of a multi-institutional validation study (CORONA subtype project).
May M, Surcel C, Capitanio U, Dell'Oglio P, Klatte T, Shariat S, Ecke T, Wolff I, Vergho D, Wagener N, Huck N, Pahernik S, Zastrow S, Wirth M, Borgmann H, Haferkamp A, Musquera M, Krabbe LM, Herrmann E, Scavuzzo A, Mirvald C, Hutterer G, Zigeuner R, Stief CG, Waidelich R, Cindolo L, Kalusova K, Brookman-May SD; Collaborative Research On Renal Neoplasms Association (CORONA) and European Association of Urology (EAU) Young Academic Urologists (YAU) Kidney Cancer Group. May M, et al. Among authors: brookman may sd. Scand J Urol. 2017 Aug;51(4):269-276. doi: 10.1080/21681805.2017.1300187. Epub 2017 Apr 12. Scand J Urol. 2017. PMID: 28399699
Prognostic significance of Fuhrman grade and age for cancer-specific and overall survival in patients with papillary renal cell carcinoma: results of an international multi-institutional study on 2189 patients.
Borgmann H, Musquera M, Haferkamp A, Vilaseca A, Klatte T, Shariat SF, Scavuzzo A, Jimenez Rios MA, Wolff I, Capitanio U, Dell'Oglio P, Krabbe LM, Herrmann E, Ecke T, Vergho D, Huck N, Wagener N, Pahernik S, Zastrow S, Wirth M, Surcel C, Mirvald C, Prochazkova K, Hutterer G, Zigeuner R, Cindolo L, Hora M, Stief CG, May M, Brookman-May SD. Borgmann H, et al. Among authors: brookman may sd, may m. World J Urol. 2017 Dec;35(12):1891-1897. doi: 10.1007/s00345-017-2078-5. Epub 2017 Aug 23. World J Urol. 2017. PMID: 28836063
p53-expression in patients with renal cell carcinoma correlates with a higher probability of disease progression and increased cancer-specific mortality after surgery but does not enhance the predictive accuracy of robust outcome models.
Morshaeuser L, May M, Burger M, Otto W, Hutterer GC, Pichler M, Klatte T, Wild P, Buser L, Brookman-May S. Morshaeuser L, et al. Urol Oncol. 2018 Mar;36(3):94.e15-94.e21. doi: 10.1016/j.urolonc.2017.11.011. Epub 2017 Dec 6. Urol Oncol. 2018. PMID: 29221641
168 results